Skip to content

Author

D. Nasioudis

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Immune Checkpoint Inhibitors: Sculpting the Landscape of Endometrial Cancer Treatment

Background: Outcomes for advanced or recurrent endometrial cancer (EC) remain poor, with historically limited systemic options beyond platinum-based chemotherapy. EC is uniquely immunotherapy-amenable among solid tumors: it harbors the highest prevalence of mismatch repair deficiency (dMMR) and microsatellite instabili...

Allan Huang, L. Mulugeta-Gordon, D. Nasioudis et al. · 0 citations
Review Open access Oct 2026

Low-grade serous ovarian cancer: 2026 expert consensus report.

This updated international consensus provides an evidence-based framework for the diagnosis and management of LGSOC while identifying priorities for future clinical research and drug development.

R. Grisham, B. Slomovitz, V. Podder et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.